Clay Daniel Jackson-Litteken

Clay Daniel Jackson-Litteken

Auto-generated profile, based on publicly available information

Clay Daniel Jackson-Litteken

Department of Molecular Microbiology, School of Medicine, Washington University in St. Louis

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in mBio
Verified
Journal Article
Open access
CJClay D. Jackson-Litteken
Clay D. Jackson-Litteken
GVGisela Di Venanzio
Gisela Di Venanzio
NLNguyen-Hung Le
Nguyen-Hung Le
NSNichollas E. Scott
Nichollas E. Scott
BDBardya Djahanschiri
Bardya Djahanschiri
MFMario F. Feldman
Mario F. Feldman
While pathogenic Acinetobacter can cause various infections, we recently found that 20% of clinical isolates come from urinary sources. Despite the clinical relevance of Acinetobacter as a uropathogen, few virulence factors involved in urinary tract colonization have been defined.

9 December 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MJManon Janet-Maitre
Manon Janet-Maitre
GVGisela Di Venanzio
Gisela Di Venanzio
CJClay D. Jackson-Litteken
Clay D. Jackson-Litteken
NSNichollas E. Scott
Nichollas E. Scott
MFMario F. Feldman
Mario F. Feldman
Although considered primarily extracellular, Acinetobacter baumannii can survive and replicate within macrophages in vitro. Intracellular bacteria are often protected from the host immune system and antibiotic treatment, potentially leading to chronic or recurrent infections. To investigate the role of intracellular A. baumannii during infection, we transferred b roncho a lveolar l avage f luid (BALF) from infected mice, containing an intracellular bacterial population, into naïve immunocompromised mice, enabling us to assess the fate of bacteria following internalization. The BALF transfer resulted in A. baumannii lung infection, indicating that intracellular bacteria can egress from host immune cells and establish infection in the lungs, thereby acting as a transient reservoir during pulmonary infection. Using dual proteomics, we characterized the A. baumannii –macrophage interactions. Infected macrophages exhibit an inflammatory and type I interferon response, marked by increased Acod1/IRG1 protein levels. Intracellular A. baumannii upregulates proteins involved in evading nutritional immunity, stress response, surface modification, and metabolic adaptation. Collectively, these findings indicate that A. baumannii employs a multifactorial strategy to persist and replicate within macrophages, potentially shaping infection dynamics in vivo and undermining therapeutic efficacy.

28 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MJManon Janet-Maitre
Manon Janet-Maitre
GVGisela Di Venanzio
Gisela Di Venanzio
CJClay D. Jackson-Litteken
Clay D. Jackson-Litteken
NSNichollas E. Scott
Nichollas E. Scott
MFMario F. Feldman
Mario F. Feldman
Although considered primarily extracellular, Acinetobacter baumannii can survive and replicate within macrophages in vitro . Intracellular bacteria are often protected from the host immune system and antibiotic treatment, potentially leading to chronic or recurrent infections. To investigate the role of intracellular A. baumannii during infection, we transferred infected bronchoalveolar lavage fluid (BALF), containing an intracellular bacterial population, to naïve immunocompromised mice. This BALF transfer resulted in A. baumannii lung infection, suggesting that intracellular bacteria may serve as a reservoir for recurrent lung infections. Using dual-proteomics, we characterized the A. baumannii -macrophages interactions. Infected macrophages exhibit an inflammatory and Type I interferon response, marked by increased ACOD1 (IRG1) protein levels. Intracellular A. baumannii upregulates proteins involved in evading nutritional immunity, stress response, surface modification, and metabolic adaptation. These findings suggest that A. baumannii employs a multifactorial strategy to survive and replicate within macrophages, which may contribute to recurrent and chronic infections, and compromise treatment efficacy. Teaser: Intracellular A. baumannii can act as a reservoir in lung infection

30 September 2022 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
CJClay D. Jackson-Litteken
Clay D. Jackson-Litteken
MCMichael W. Curtis
Michael W. Curtis
BABrittany A. Armstrong
Brittany A. Armstrong
AKAparna Krishnavajhala
Aparna Krishnavajhala
SFSerhii Filatov
Serhii Filatov
JLJob Lopez
Job Lopez

3 February 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
CJClay Daniel Jackson-Litteken
Clay Daniel Jackson-Litteken
GVGisela Di Venanzio
Gisela Di Venanzio
NLNguyen-Hung Le
Nguyen-Hung Le
NSNichollas E. Scott
Nichollas E. Scott
BDBardya Djahanschiri
Bardya Djahanschiri
MFMario F. Feldman
Mario F. Feldman
Acinetobacter baumannii is an opportunistic pathogen of growing concern, as isolates are commonly multidrug resistant. While A. baumannii is most frequently associated with pulmonary infections, a significant proportion of clinical isolates come from urinary sources, highlighting its uropathogenic potential. The type II secretion system (T2SS) of commonly used model Acinetobacter strains is important for virulence in various animal models, but the potential role of the T2SS in urinary tract infection (UTI) remains unknown. Herein, we used a catheter-associated UTI (CAUTI) model to demonstrate that a modern urinary isolate, UPAB1, requires the T2SS for full virulence. A proteomic screen to identify putative UPAB1 T2SS effectors revealed an uncharacterized lipoprotein with structural similarity to the intimin-invasin family, which serve as type V secretion system (T5SS) adhesins required for the pathogenesis of several bacteria. This protein, designated InvL, lacked the β-barrel domain associated with T5SSs, but was confirmed to require the T2SS for both surface localization and secretion. This makes InvL the first identified T2SS effector belonging to the intimin-invasin family. InvL was confirmed to be an adhesin, as the protein bound to extracellular matrix components and mediated adhesion to urinary tract cell lines in vitro. Additionally, the invL mutant was attenuated in the CAUTI model, indicating a role in Acinetobacter uropathogenesis. Finally, bioinformatic analyses revealed that InvL is present in nearly all clinical isolates belonging to international clone 2, a lineage of significant clinical importance. In all, we conclude that the T2SS substrate InvL is an adhesin required for A. baumannii uropathogenesis.IMPORTANCE: While pathogenic Acinetobacter can cause various infections, we recently found that 20% of clinical isolates come from urinary sources. Despite the clinical relevance of Acinetobacter as a uropathogen, few virulence factors involved in urinary tract colonization have been defined. Herein, we identify a novel type II secretion system effector, InvL, which is required for full uropathogenesis by a modern urinary isolate. Though InvL has predicted structural similarity to the intimin-invasin family of autotransporter adhesins, InvL is predicted to be anchored to the membrane as a lipoprotein. Similar to other invasin homologs however, we demonstrate that InvL is a bona fide adhesin capable of binding extracellular matrix components and mediating adhesion to urinary tract cell lines. In all, this work establishes InvL as an adhesin important for Acinetobacter’s urinary tract virulence, and represents the first report of a type II secretion system effector belonging to the intimin-invasin family.